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Abstract: This article explores the role of researchers as innovation drivers in the public healthcare sector. The Triple 
Helix model is proposed for the analysis of the role of public hospitals in innovation processes. We discuss the role of 
public hospitals in innovation and in economic and social development, and identify this role as a ‘fourth mission’ of 
hospitals in addition to their widely recognized threefold function of healthcare provision, education and research. We 
discuss the evolution of hospital administration from healthcare towards the ‘entrepreneurial hospital’ model. More 
specifically, we investigate the extent to which the incorporation of full-time researchers can help to foster innovation at 
research and healthcare centres affiliated with the Spanish National Health System. Data were obtained through a survey 
of researchers, research group leaders and heads of departments and centres where these researchers worked, as well 
as through content analysis of researchers’ annual reports.
Keywords: Health innovation; biomedical research; full-time researchers; hospitals; public healthcare sector; R&D&I 
programme evaluation.
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Resumen: Se estudia el papel de los investigadores como promotores de la innovación en el sector sanitario público. 
Se propone el modelo de la Triple Hélice para el estudio del papel de los hospitales en los procesos de innovación. 
Se identifica la innovación y la contribución al desarrollo económico y social como la ‘cuarta misión’ de los hospitales 
públicos, adicional a su triple misión asistencial, docente e investigadora. Este enfoque aboga por una evolución desde 
el modelo asistencial tradicional hacia el modelo del ‘hospital emprendedor’. A través del Programa FIS/Miguel Servet, 
se investiga en qué medida la incorporación de investigadores contribuye a fomentar la innovación en los centros del 
Sistema Nacional de Salud español. Los datos proceden de sendas encuestas a los investigadores y a los responsables de 
los grupos y de los distintos departamentos y centros a los que éstos se incorporaron, así como del análisis de contenido 
de sus informes anuales. 
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1. INTRODUCTION
One of the dogmas of the economics of 
innovation is that companies generate innovation, 
whereas the public sector suffers from what Potts 
and Kastelle (2010) call an innovation deficit or 
challenge. Nevertheless, recent years have seen a 
growing awareness that innovation is not restricted 
to the private sector, with public sectors such as 
education and healthcare, among others, also 
considered sources of innovation (OECD/Eurostat, 
2005; Djellal and Gallouj, 2005; Koch et al., 2006; 
Petty and Heimer, 2011; Hughes et al., 2011). 
Innovation is basic for the maintenance and 
improvement of healthcare provision and has 
evident, well-documented benefits for the 
healthcare system (Cutler and McClellan, 2001; 
Brach et al., 2008; Font et al., 2008; Pons-Ràfols, 
2010). “Understanding how innovations […] can 
be effectively introduced in health systems and 
how these innovations interact with health system 
variables to influence health outcomes” has been 
identified as a challenge for health systems in order 
to achieve good health efficiency (Atun, 2012). 
However, measuring innovation and evaluating its 
impacts in the health sector is a field in a relatively 
incipient phase of development (Koch et al., 2006; 
Weiss, 2007; Fung et al., 2011). 
Research and innovation are closely related. 
Although it is true that many innovations are 
not based in scientific knowledge, some authors 
consider research and technological development as 
instruments for attaining innovation (Commission 
of the European Communities, 2003). Many 
authors have found science and technology to be 
linked to both technological and non-technological 
innovation (Carpenter et al., 1980; Narin and 
Olivastro, 1992; Petty and Heimer, 2011). 
According to Friedman (2002), winner of the Nobel 
Prize for Physics in 1990, “innovation is the key to 
the future, but basic research is the key to future 
innovation”, and symbiotic research, understood as 
the synthesis of basic research, applied research 
and product development, plays a crucial role in 
the creation of new technologies. 
In this regard, researchers in the healthcare 
sector can play a significant role as innovation 
drivers and fosterers. Nevertheless, the existing 
literature on innovation in hospital-based healthcare 
has failed to investigate the role of actors involved 
in innovation other than medical staff (Djellal and 
Gallouj, 2007).
The present article is part of a research project 
one of whose aims is to investigate the role of 
researchers as innovation drivers in the public 
healthcare sector. Using the Triple Helix model as 
a framework for the analysis of the role of public 
hospitals in knowledge generation and innovation 
processes, we discuss their role in innovation and 
in economic and social development, and identify 
this role as a ‘fourth mission’ of hospitals in addition 
to their widely recognized threefold function of 
healthcare provision, education and research. We 
discuss the evolution of hospital administration 
from healthcare towards the ‘entrepreneurial 
hospital’ model. More specifically, we investigate 
the extent to which the incorporation of full-
time researchers can help to foster innovation at 
research and healthcare centres affiliated with the 
Spanish National Health System (NHS).
2. BACKGROUND. INNOVATION AT THE 
SPANISH NHS AND THE FIS/MIGUEL SERVET 
PROGRAMME
Earlier analyses found the Spanish NHS to have 
shortcomings in the transfer of the research-
based knowledge to clinical practice. The Spanish 
NHS is involved only rarely in the generation of 
research returns such as diagnostic tools, applied 
health treatments and new technologies, and has 
generated few patents (Meneu et al., 2005; de 
Pablo and Arenas, 2008). In addition, the Spanish 
model of biomedical and technological innovation 
is characterized, according to Bigorra (2010), by 
the limited role of hospitals, which are mainly 
restricted to providing services for clinical trials and 
enabling doctors to contribute to the dissemination 
of knowledge about therapeutic novelties. Oteo-
Ochoa and Repullo-Labrador (2005) identified, 
among the factors that hinder innovation in the 
Spanish health sector, the insufficient number of 
institutionally supported R&D programmes, and 
the technical obstacles derived from the shortage 
of qualified personnel with technological skills. 
Moreover, the system of research evaluation 
neither encourages nor rewards innovation, except 
that which results in patents.
The generation of scientific and technological 
capacities at NHS hospitals constitutes a strategic 
action of prime importance in Spanish health public 
policies. In this regard, together with the creation, in 
recent years, of research centres of excellence and 
international prestige, public policies are making 
substantial efforts to enhance the research activity 
of public hospitals, as institutions with a threefold 
function: healthcare provision, education and 
research (de Pablo and Arenas, 2008; Gomis, 2009). 
Improving the capacity of Spanish NHS centres as 
generators not only of scientific knowledge but also 
of innovation is one of the challenges of the Carlos 
III Health Institute1. Its commitment to innovation 
has been explicitly manifested in the statement 
of programme objectives, and through initiatives 
currently underway within the framework of the 
Strategic Health Action2. To this end, the FIS/
Miguel Servet Research Contract Programme 
constitutes one of the most important strategic 
actions. This programme was created in 1998, 
and in 2008 it was renamed after Miguel Servet, 
the illustrious 16th century physician, scientist 
and humanist. Previously it was known as the FIS 
(Fondo de Investigación Sanitaria [Health Research 
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Fund]) Programme, and the researchers it funded 
were known as FIS researchers. Hereafter, we will 
refer these actors as the FIS Programme and FIS 
researchers, respectively. 
The programme’s objectives are to incorporate 
researchers with excellent training within the 
Spanish NHS in order to improve the health 
system’s research capacity, to provide research 
units and groups at healthcare establishments 
with multidisciplinary capacity, and to promote 
the creation of stable research groups within the 
Spanish NHS. Researchers are supported with a 
three-year contract which can be renewed for three 
more years if their work is evaluated favourably. 
Innovation is among the goals of the National 
Research, Development and Innovation (RDI) Plan. 
By incorporating basic researchers into research at 
Spanish NHS hospitals and centres, the programme 
may contribute to this aim of the RDI Plan. As 
other authors previously noted, we are aware that 
the path from basic research (the production of 
knowledge) to innovation is a complex one that, 
as noted by De Pouvourville (2001), “is far from 
being straightforward”. Nevertheless, considering 
that scientific research can be an instrument to 
attain innovation, our aim was to determine the 
contribution of these researchers not only to 
research, but also to innovation.
3. TOWARDS A CONCEPTUAL FRAMEWORK 
FOR THE ANALYSIS OF THE ROLE OF PUBLIC 
HOSPITALS IN KNOWLEDGE GENERATION 
AND INNOVATION PROCESSES
In this section we review the main theoretical 
approaches and conceptual frameworks used in 
previous research about innovation. As a theoretical 
grounding for our empirical study, we discuss the 
potential applicability of previous theories to the 
study of innovation in the healthcare area.
Current empirical studies and academic 
discussions on innovation are eminently multi-
disciplinary. Theoretical and methodological 
contributions have come from many different 
areas, and have given rise to a broad corpus of 
knowledge which will not be reviewed in depth 
here; readers are referred to recent publications 
for further information (Fagerberg and Verspagen, 
2009; Bhupatiraju et al., 2012; Fagerberg et al., 
2012; Fernández-Esquinas, 2012; Martin, 2012).
The concept of innovation and the traditional 
linear model
The concept of innovation draws from the 
Schumpeterian tradition, according to which 
innovation has a basically economic purpose. This 
initially led to a linear conception of innovation 
(Godin, 2006) that some authors have called 
Mode 1 of knowledge production (Gibbons et al., 
1994). In short, the traditional linear model of 
innovation postulated that “innovation starts with 
basic research, is followed by applied research 
and development, and ends with production and 
diffusion” (Godin, 2006). 
This view of innovation began to be questioned by 
authors who were interested in the roles of different 
actors in the innovation process (in addition to 
the business sector) and in different forms of 
innovation other than technological innovation 
(Hochgernet et al., 2011; Echeverría and Merino, 
2011). Thus, the new paradigm takes into account 
public sector organizations, public authorities, civil 
society organizations, trade unions and consumers 
(Commission of the European Communities, 2006; 
Hughes et al., 2011). Moreover, it also considers 
non-market-oriented processes such as hidden 
innovation3 (for example, social innovation4). 
Within this new explanatory context, innovation 
in healthcare and in the hospital setting is clearly 
related to these different agents and forms of 
innovation.
The ‘Innovation Systems’ and the ‘Triple 
Helix’ approaches to the study of innovation. 
Their application to the study of innovation 
within health systems
As a result of this shift and some important 
considerations regarding the concept of innovation, 
a series of proposals have been made from an 
interactive or dynamic standpoint (Etzkowitz, 
2003). Their main precursors were the Innovation 
Systems approach from the 1980s and the Mode 2 
approach from the 1990s. The starting point that 
these two approaches share is their critique of the 
linear model of innovation along with their emphasis 
in interactivity among all agents involved. In the 
newer conceptualization, innovation is understood 
as a social system. The Mode 2 approach 
concentrates on the description of a new system of 
production of flexible, dynamic, trans-disciplinary 
and socially distributed knowledge (Gibbons et al., 
1994), whereas the Innovation Systems approach 
focuses on the economic and sociological aspects 
of innovation and gives greater prominence to the 
role of institutions. This approach was introduced 
by Freeman’s (1987) and Lundvall’s (1988, 1992) 
work in National Innovation Systems. Their 
proposals intrepret innovation as a process in 
which actors and contextual factors are “important 
elements of any given system for the creation and 
use of knowledge for economic purposes” (Sharif, 
2006).
This initial work subsequently gave way to other 
variants that shared the same systemic vision 
while emphasizing other levels of organization in 
addition to the national setting. Notable among 
these variants are the systems of innovation 
based on clusters (Malmberg and Maskell, 2002), 
sectors (Malerba, 2002), technologies (Carlsson 
et al., 2002) or regional settings (Doloreux and 
Parto, 2005).
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Nevertheless, authors such as Edquist (1997) 
have pointed out a theoretical shortcoming in 
some of these non-linear proposals, and have 
recommended that they be used as framework 
models rather than closed theories with full 
explanatory capacity. In addition, some authors 
have criticized the excessive importance given to 
companies compared to other agents involved in 
innovation (Etzkowitz and Leydesdorff, 2000). A 
further potential limitation is that these approaches 
have tended to prioritize the level of analysis (e.g., 
national, regional or sectorial) at the expense of 
the view that research and innovation policies must 
be developed on a multi-level governance basis, 
including the national, transnational and regional 
levels (Edler et al., 2003).
Although innovation is not currently one of its 
principal objectives, different institutions within the 
NHS (e.g., hospitals and their associated research 
centres) can be considered part of national (and 
regional) innovation systems, understood as 
“the network of institutions in the public and 
private sectors whose activities and interactions 
initiate, import, modify and diffuse technologies” 
(Freeman, 1987), as well as “the system of 
interconnected institutions to create, store and 
transfer the knowledge, skills and artefacts which 
define new technologies” (Metcalfe, 1995). The 
relationship between the National Health System 
and the National Innovation System can also be 
characterized from the approach proposed by Arnold 
and Kuhlman (2001). In their model, hospitals and 
other NHS centres may play a role in the education 
and research sectors. At the same time, they 
can be viewed as intermediaries between these 
sectors and the industrial system, whereby they 
assume the role of intermediate organizations with 
the capacity to provide extramural R&D services 
to industry (e.g., the pharmaceutical sector). In 
addition, the NHS, as a designer and co-ordinator 
of health and research policies, can be considered 
an element in the political system, as described by 
Arnold and Kuhlman, or in the institution sector, as 
proposed by Fisher (2001). On the other hand, the 
role of hospitals as entities that request and use 
innovation cannot be disregarded.
Nevertheless, some authors have drawn attention 
to the fact that innovation is dependent on other 
conditions in addition to scientific, technological, 
industrial and financial support (López Cerezo, 
2004). It also requires social agents not directly 
involved in R&D activities or not directly tied to 
the business and finances world, i.e., agents that 
are not considered by the Innovation Systems 
model. Given their threefold function in healthcare, 
education and research, NHS hospitals can be 
considered one of these social agents. In addition, 
the social context is a determinant for innovation to 
succeed, but is frequently overlooked in analyses 
of innovation systems. As a result, the role of 
social agents (e.g., consumers or other direct 
beneficiaries of innovation, and people affected by 
or interested in innovation) is disregarded. Given 
that “the success of innovation depends on the 
favourable or at least non-hostile reaction of these 
and other social agents” (López Cerezo, 2004), 
in the healthcare arena it is essential to consider 
health professionals themselves as innovation 
users and patients as the ultimate beneficiaries of 
innovation. This is a drawback in the Innovation 
Systems approach to the study of innovation in 
healthcare.
A model that appears better suited to our 
analysis of the roles of public health service 
hospitals is the Triple Helix approach (Etzkowitz 
and Leydesdorff, 2000), which brings together the 
main contributions from earlier dynamics-based 
approaches. The Triple Helix proposal focuses 
“on the network overlay of communications 
and expectations that reshape the institutional 
arrangements among universities, industries and 
governmental agencies”, and interprets innovation 
to be increasingly based upon the ‘Triple Helix’ 
of university–industry–government interactions 
(Etzkowitz, 2003: 293).
Considered in these terms, this approach 
may appear unlikely to be useful in attempts to 
analyse innovation at NHS institutions. However, 
the model is usually expressed in terms of 
interactions between academia (rather than simply 
universities), industry and government (Etzkowitz 
and Leydesdorff, 2000). In this model, academia 
includes universities and other knowledge-
producing institutions, which are seen to play 
a new role in society (Etzkowitz, 2003). When 
formulated in these terms, the model offers a 
better conceptual fit to our purposes, provided that 
university hospitals are assumed to be knowledge-
producing institutions where education and 
research take place as academic endeavours.
Healthcare institutions can be viewed as a different 
strand in the Triple Helix model. This is possible 
because the model is not a rigid framework, but 
rather allows new elements to be incorporated into 
the framework when one element is missing and 
another has appeared (Etzkowitz, 2003). Other 
essential characteristics of the Triple Helix are “the 
recognition that institutions may perform multiple 
missions”, the corollary that “the secondary 
functions performed are the primary functions 
of the other spirals in the Triple Helix”, and the 
recognition that “it is possible for an institutional 
sphere to play multiple roles without the original 
role being degraded or harmed” (Etzkowitz, 2003). 
This characteristic of the model allows hospitals 
to be considered as Triple Helix partners that take 
on some of the capabilities of other agents while 
maintaining their primary role and distinct identity 
(Etzkowitz, 2003). In this Triple Helix model of 
institutional relationships with a role in healthcare, 
the core mission of university hospitals continues to 
be that of healthcare provision, while at the same 
time these hospitals also assume a role canonically 
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ascribed to one of the other strands in the helix, 
i.e., the education and research roles of academia. 
The ‘fourth mission’ of hospitals. From 
healthcare to the entrepreneurial hospital
Within the Triple Helix framework, a two-stage 
revolution has been identified (Etzkowitz and 
Leydesdorff, 2000) through which universities 
have been transformed from “a support structure 
for innovation, providing trained persons, 
research results, and knowledge to industry” 
into organisms that are increasingly “involved 
in the formation of firms, often based on new 
technologies originating in academic research” 
(Etzkowitz, 2003). In the first stage or first 
academic revolution, universities took on the 
function of research, evolving from teaching 
institutions into centres that combined teaching 
with research. The so-called second academic 
revolution comprised the change from research 
university to entrepreneurial university 
through the integration of economic and social 
development with teaching and research. 
This process has occurred at universities that 
successfully embraced the third mission – 
contributing to the economy and society – in 
addition to the two traditional roles of education 
and research (Martin, 2012). 
In the context of the NHS, hospitals can be 
seen as institutions with a broader role than the 
widely recognized threefold function of healthcare 
provision, education and research. Just as a third 
mission has been identified for universities, a 
‘fourth mission’ of hospitals can be seen to consist, 
in general terms, of innovation and knowledge 
transfer. This mission is understood to include 
innovation in health technologies and healthcare 
services, such that the outcomes can be transferred 
to society and thus contribute to economic and 
social development. In order to be compatible 
with the Triple Helix model, this mission can be 
considered to complete the circle by imbricating 
with healthcare to constitute the ‘third mission’ 
of healthcare institutions. Ultimately, this third 
mission of hospitals, which includes healthcare 
and the translation of research and innovation to 
healthcare provision and patient care, becomes 
their main, fundamental mission. This mission can 
transform hospitals, in Zawdie’s (2010) words, into 
“power-houses of innovation, and hence strategic 
agents of sustainable development” in addition to 
healthcare providers.
In countries whose national health systems are 
troubled by the disconnect between healthcare 
provision and research, and where research is not 
well developed at public hospitals (as is the case in 
Spain [FECYT, 2005a; Bigorra, 2010]), the ‘research 
revolution’ is still in progress. At the same time, 
however, hospitals in these countries are preparing 
to face the ‘innovation and transfer revolution’. At 
Spanish public hospitals the first revolution has 
been characterized by the change from healthcare 
institutions to healthcare and teaching hospitals 
(i.e. university hospitals), as a result of successful 
education and training activities5. Spanish public 
university hospitals are now in the midst of a second 
revolution – a process whereby their research 
function is being fully incorporated into the centres’ 
usual activities. This ‘second healthcare revolution’ 
from teaching hospital to research hospital can 
be considered equivalent to the ‘first academic 
revolution’ described above. In addition, hospitals 
face the challenge of a third revolution in which 
they are taking steps to integrate innovation and 
economic and social development with healthcare, 
education and research. 
Thus university hospitals face the challenge of 
evolving, as universities have done, to become 
‘entrepreneurial hospitals’. Like the entrepreneurial 
university, the entrepreneurial hospital can be 
defined as a hospital “that encompasses the 
conservation and passing on of knowledge, 
integrating [in addition to healthcare] education 
and research, as well as supporting innovation” 
(Etzkowitz, 2003). Like the entrepreneurial 
university, the entrepreneurial hospital, although it 
has “a considerable degree of independence from 
the state and industry”, also requires a “high degree 
of interaction with these institutional spheres”. 
The entrepreneurial hospital is closely linked to 
industries (e.g., the pharmaceutical industry) which 
produce goods and services; at the same time, 
the entrepreneurial hospital carries out research 
and provides training in their particular areas of 
expertise. Hospitals that operate according to this 
model are also linked to government, the ultimate 
arbiter of the rules of the game and potential provider 
of funding to support research and launch new 
enterprises. Like the full-fledged entrepreneurial 
university (Etzkowitz, 2003), a characteristic of the 
full-fledged entrepreneurial hospital is that research 
goals are defined by outside sources in addition to 
hospital experts in different scientific disciplines, in 
a two-way flow between research on the one hand 
and economic and social activities on the other. 
Within such a framework, translational research, 
i.e. knowledge flow from bed to bench and from 
bench to bed, remains a distinctive feature of the 
entrepreneurial hospital. As hybrid organizations 
emerging at the interfaces between the different 
institutional spheres in the Triple Helix model, 
research hospitals and entrepreneurial hospitals may 
give rise to spin-offs and other hybrid organizations. 
These arrangements, as stated by Etzkowitz and 
Leydesdorff (2000), are often encouraged, but not 
controlled, by governments through new “rules of 
the game”, direct or indirect financial assistance or 
new actors6.
In contrast to classical models that view 
institutions according to their traditional functions 
(such as the national Innovation Systems model, 
which considers industry as the primary institutional 
sphere and focus of innovation analysis, with 
government and university playing only supporting 
roles), the Triple Helix model focuses on new 
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activities “as a potentially productive innovation 
in innovation” (Etzkowitz, 2003). Classical models 
may thus be more appropriate to analyse “classical” 
healthcare-provision hospitals, whereas the Triple 
Helix model is better suited to the analysis of 
entrepreneurial hospitals involved in the missions 
described above. 
Our approach to the study of innovation in 
Health Systems is consistent with the structural 
and procedural perspective that contemplates 
not only market- and profit-oriented innovation 
but also innovation that addresses social needs. 
We consider innovation as embedded in the 
science-technology-society system, rather than 
in the science-technology-industry system. In the 
former, industry forms an important part of society 
although the system also comprises other agents 
(López Cerezo, 2004), including health services.
We approach the study of innovation as the 
sociology of innovation, which we view as a hybrid 
discipline stemming from the sociology of science 
and the sociology of economy. Studies in the 
sociology of innovation thus set out to understand 
innovation as a social process. Our approach uses 
the sociology of science to analyse innovation, 
because it “provides the keys to study scientific 
communities and organizations that generate the 
knowledge that gives rise to innovations with a 
broad social impact” (Fernández Esquinas, 2012). 
These communities include universities, research 
centres, and, as in the present study, healthcare 
institutions. There were two main reasons for 
choosing this perspective to study innovations 
derived from scientific research and based on 
scientific discoveries and applied technology: first, 
the role of the healthcare sector in the generation 
of innovation, and second, the fact that innovation 
is rooted in the structure of society and culture.
The study of the interphase that arises as a result 
of the incorporation of basic researchers within 
the NHS environment entails looking beyond the 
traditional Innovation Systems approach, because 
– as noted by Fernández Esquinas (2012) – this 
approach “limits the observations to those sets of 
rules that affect the interrelation of organizations”. 
It is therefore necessary to consider different sets 
of rules that condition the work of researchers 
and healthcare personnel in scientific institutions 
in general, and in NHS institutions in particular. In 
addition, the set of norms and values governing 
scientific research and the production, diffusion 
and consumption of scientific knowledge need to be 
considered. The approach based on the sociology 
of innovation makes it possible to observe the 
manner in which particular values and norms 
typify particular institutions. This correspondence 
is interesting when basic researchers – who learn 
a set of norms and values at laboratories at R&D 
centres – join hospital-based research groups 
where a different set of values and norms is likely 
to apply.
The notion of social structure, although not 
usually considered in innovation studies, is 
nevertheless essential to understand innovation 
at Health Systems. Social structure, as noted 
by Fernández Esquinas (2012), is the sphere 
of individual and collective interests backed by 
variable amounts of power and resources. The 
social structure is composed by people who play 
different roles according to a hierarchical scale, and 
the components of this structure are formed by the 
skills and resources that give the actors the ability 
to act or force others to act. Within the scope of the 
present study, the integration of basic researchers 
into hospitals places them in a social structure very 
different from that of the research laboratories 
most of them came from. The social structure 
at Spanish public hospitals is characterized by 
marked hierarchization, a traditional prevalence of 
clinical research, a disconnect between healthcare 
provision and research, and the absence of an 
established research career path within the Spanish 
NHS (Rodés and Mayor, 2003; FECYT, 2005b; 
Bornstein and Licinio, 2011). These features may 
act as determining factors in the production, 
implementation and diffusion of innovation, and 
may also provide keys to understanding to what 
extent hospitals and other healthcare institutions 
may be considered innovative organizations.
4. METHODS
A detailed description of the methodology used in 
this research was published previously (Rey-Rocha 
and Martín-Sempere, 2012). In that article we 
explained the population and sample studied, the 
research instruments used for data collection, the 
data analysis and statistical procedures. However, 
to facilitate comprehension of the present article, 
the most relevant aspects of this methodology are 
summarized below.
The universe to be studied consisted of the 
different stakeholders in the FIS Programme. This 
included, on the one hand, the population of 192 
FIS researchers funded by the first four calls of 
the Programme (1998–2001) who worked at 60 
different hospitals and five research centres of the 
Spanish NHS. In addition, the universe included 
the population of 277 leaders of research groups 
and heads of the different departments and 
centres where FIS researchers worked (referred to 
hereafter as FIS hosts).
We used a web-based survey to obtain data 
from the population of FIS researchers. In 
addition, a detailed structured questionnaire was 
administered face-to-face to FIS hosts. The overall 
response rate was 70.8 % (136 valid answers) for 
researchers and 52 % (144 individuals) for hosts. 
In addition, an initial attempt was made to assess 
innovation quantitatively by examining data on 
patenting activity obtained from FIS researchers’ 
final activity reports. 
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We asked FIS researchers whether the research 
work they carried out during their contract helped 
produce or implement innovation. To facilitate 
the identification of innovation, the concepts of 
innovation used in the survey were explained 
together with the relevant item. In accordance with 
the OECD/Eurostat Oslo Manual guidelines (1997) 
‘technological innovations’ were defined as those 
related to the introduction or use of technologically 
new or substantially changed products (goods 
or services) and processes. ‘Non-technological’ 
innovation covered all innovation activities that did 
not meet the definition of technological innovation, 
including organizational and managerial 
innovations. An innovation was considered to have 
been ‘implemented’ if it had been introduced on 
the market (product innovation) or used within a 
production process (process innovation). 
Meaning analysis of the responses to open 
questions was approached by both ‘meaning 
condensation’ and ‘meaning categorization’. 
First, significant information was extracted from 
texts and condensed into briefer, more succinct 
formulations, and the constructs implied by the 
data were identified. These constructs were further 
categorized and coded. Quantitative data were 
analysed with the Statistical Package for Social 
Sciences (SPSS) for Windows, version 15.0.
5. RESULTS 
In order to better understand their role as 
innovation drivers, it is worth recalling some of the 
researchers’ main characteristics along with the 
activities they carried out during their contract. 
Under the FIS Programme, postdoctoral researchers 
from different academic backgrounds joined 
research groups working at Spanish NHS centres. 
Most FIS researchers held a doctorate in biology, 
and some held a doctorate in medicine and surgery, 
pharmacy or another academic field (Rey-Rocha 
et al., 2012). FIS researchers mainly undertook 
basic research exclusively or in combination 
with clinical research. They collaborated mainly 
with clinical researchers at their own centres, 
whereas extramural collaborations most frequently 
involved basic or basic + clinical researchers (Rey-
Rocha and Martín-Sempere, 2012). The survey 
results showed that most FIS researchers (60%) 
worked full-time in research, whereas two fifths 
of the participants alternated research with other 
activities, mainly administrative and management 
tasks, teaching, and science communication. Less 
than 24% worked in development activities (rather 
than research activities) or healthcare provision.
Around three quarters of the scientists surveyed 
considered that during their FIS research contract, 
their group did not produce or implement any 
technological innovation, or did so as a result of 
other research lines different from their own. This 
percentage was even higher (more than 90%) for 
non-technological innovation. The contribution 
of the small group of researchers who answered 
affirmatively was focused mainly on technological 
(product and process) innovation, as well as on the 
production of innovation in organizational structures 
and corporate strategic orientations (Table I). 
On the other hand, 80.9% of the respondents 
felt that their research work did not directly 
help their group to produce or implement any 
technological process innovation (Table I). Initially, 
this may appear to contradict the fact that 92.7% 
believed they had helped their group to apply new 
techniques, and 89.7% felt they had helped their 
group to develop new techniques (Table II). 
Table I. Do you think the research you carried out during your FIS contract helped to produce or imple-
ment any innovation?
% of researchers 
surveyed
(n=136)
My group did not produce 
or implement any 
innovation during
my stay
Yes it did, but as a 












innovation 74.3 3.7 12.5 9.6
Technological process 
innovation 75.0 5.9 14.0 5.1
Non-technological innovations
Implementation of advanced 
management techniques 91.9 1.5 4.4 2.2
Introduction of significantly 
changed organizational 
structures
84.6 1.5 10.3 3.7
Implementation of new 
or substantially changed 
corporate strategic 
orientations
83.8 2.9 8.1 5.1
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Most techniques applied or developed by FIS 
researchers fall into the fields of molecular biology 
and communication and image engineering. 
Examples are given below:
Basic molecular and cell biology techniques such 
as real-time thermocycler, flow cytometer, cell 
cultures, gene overexpression and silencing, 
protein interactions, tissue arrays and cDNA (FIS 
researcher who led a newly created research 
group at a hospital pathology research unit, and 
who carried out basic and clinical research)
Molecular genetics techniques such as [testing 
for] loss of heterozygosity, promoter methylation, 
gene expression, etc. (FIS researcher who led 
a newly created research group at a hospital 
molecular oncogenetics laboratory, and who 
carried out basic and clinical research)
Confocal microscopy, various molecular 
biology techniques such as recombinant DNA, 
electrophoretic mobility shift assay, real-time 
polymerase chain reaction, gene transfer into 
cells by transfection or adenoviral agents (FIS 
researcher who led a newly created research 
group at a hospital bone metabolism laboratory 
where she carried out exclusively clinical research)
But even if the respondent specifically mentioned 
having developed a new technique, he or she did 
not consider that it contributed to innovation, or 
did not regard this development as an innovation. 
This situation is well reflected by the comment by 
one of researchers surveyed who, despite reporting 
that work contributed to the development of many 
techniques, stated that none of his work led to the 
production or implementation of innovation. 
In our laboratory we perfected animal models 
and cell culture, molecular biology, gene 
transfer and flow cytometry techniques. […] 
In the future our research line may lead to 
products or processes that reach the market, 
but at the moment our main objective has been 
and continues to be knowledge generation, i.e., 
to answer questions. (FIS researcher who led a 
newly created research group at a hospital blood 
and tissue bank, and who carried out exclusively 
basic research)
The view expressed above contrasts with that 
of researchers who, regardless of whether their 
results reached the market or not, identified 
a wide range of both technological and non-
technological innovations. These include not only 
innovations of economic value (i.e., those which 
helped improve productivity and competitiveness), 
but also social innovations that facilitated the 
availability, quality and efficiency of healthcare, 
and healthcare innovations such as care centres 
that increased efficiency in the use of human and 
financial resources and improved the management 
of demand pressures. Examples of these technical 
and non-technical innovations are given below:
We patented, together with a pharmaceutical 
company, products with anti-tumour activity 
against colorectal cancer which we are extending 
to other tumour types. (FIS researcher who led 
a newly created research group at a hospital 
gastrointestinal research laboratory, where he 
carried out basic, clinical and pharmacological 
research)
Commercialization of the sperm chromatin 
dispersion (SCD) test by two national companies. 
We patented a new siRNA anti-CD40 molecule 
(product innovation) and created a new process 
to incorporate it into kidney tissue (process 
innovation) that consists of injection via the renal 
artery and immediate organ electroporation. 
(FIS researcher who created a sub-group within 
a research group on experimental nephrology 
and transplantation, and who carried out basic, 
clinical and pharmacological research)
We originated and developed molecular diagnosis 
procedures with high-performance and highly 
reliable techniques for research and molecular 
diagnosis tasks. [These procedures] were not 
available before I joined the group. Thanks to 
these techniques, a Molecular Diagnosis Service 
was established oriented towards molecular 
diagnosis for the pathologies of interest, 
where samples are currently processed from 
many national and international centres. (FIS 
researcher who led a newly created research 
group at a hospital endocrinology department, 
and who carried out basic and clinical research)
Table II. Do you think your incorporation as a FIS researcher helped to apply or develop new techniques 
by the host group or department?






Yes, my incorporation has been a determining factor 59.6 51.5
Yes, my incorporation has contributed to some extent 33.1 38.2
No, my incorporation had no effect 4.4 8.1
No new techniques have been applied or developed 2.9 2.2
Total 100 100
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Participation in the Strategic Plan at my Centre 
and in the Mental Health Plan of the Autonomous 
Region. (FIS researcher who led a newly created 
research group at a hospital research unit, and 
who carried out basic and clinical research)
The contribution of these researchers to innovation 
at the hospitals and research centres where they 
worked was further investigated from the point of 
view of the heads of their administrative units and 
research group leaders. They were asked to rate the 
extent to which the Programme fostered innovation 
within the Spanish NHS. The average rating was 
a mid-range value (3.1) on a scale from 1 (not at 
all) to 5 (a lot) (Table III), reflecting a remarkable 
consensus among informants in all categories. 
Even more informative is the distribution of 
responses: around one third of our informants felt 
that the FIS Programme had contributed a lot or 
quite a lot to innovation. Particularly noteworthy 
was the proportion of positive responses from 
healthcare professionals closest to the researchers: 
31% of research group leaders and 37% of hospital 
research managers felt that the programme 
researchers had helped to foster innovation. 
Professionals more directly related with medical 
services (heads of clinical services) were more 
divided in their opinions, the largest proportion 
(42%) having a positive perception of the 
importance of FIS researchers as catalysts of 
innovation processes. However, this group also 
accounted for the largest percentage of informants 
who felt that programme researchers had helped 
only slightly or not at all (39%). For their part, 
only 18.5% of hospital administrators, who a priori 
are the actors most removed from research and 
FIS researchers, felt that the latter had played a 
large role in facilitating innovation, most of them 
indicating that the Programme had contributed ‘to 
some extent’.
As we have seen, FIS researchers reported that 
most of their work involved basic research. FIS 
hosts confirmed this and considered this to be one 
of the reasons why FIS researchers were not more 
focused on innovation. Two of the informants at a 
large hospital that hosted many FIS researchers 
highlighted this point from the perspective of a 
research director and a research group leader:
[FIS researchers] have brought in a breath of 
fresh air and have incorporated basic research, 
which may eventually be applicable at the 
hospital, sooner or later. (Hospital research 
director)
Innovation is not transferred to the [Spanish] NHS. 
Thanks to the programme, clinicians are brought 
closer to basic research, but FIS researchers 
‘do not push’, do not translate innovation to the 
System. (Research group leader)
FIS hosts emphasized time as the main reason 
why the incorporation of these researchers did not 
contribute significantly to strengthening innovation 
within the Spanish NHS: 8.3% of them were of 
the opinion that six years is not long enough for 
their contributions to materialize, as the following 
quotations indicate:
It is too early to talk about innovation. We 
haven’t reached the ‘I’. (Head of a hospital 
service and research group leader)
I don’t think they had enough time. Innovation 
needs research first. Research is part of the 
innovation process. And they haven’t had 
enough time yet. (Hospital administrator)
Innovation is a long-term concept. Six years is 
not long enough. (Hospital administrator)
An open question we put to FIS hosts solicited 
their opinion about the main effects the 
incorporation of FIS researchers had on hospitals 
and research centres, and on their different units, 
departments and groups. Only two of them, the 
(% of FIS hosts) HA (n=27) RM (n=46) HS (n=36) GL (n=35) Total (n=144)
5 = a lot 7.4 8.7 8.3 11.4 9.0
4 = quite a lot 11.1 28.3 33.3 20.0 24.3
3 = to some extent 40.7 23.9 5.6 40.0 26.4
2 = slightly 22.2 23.9 25.0 17.1 22.2
1 = not at all 3.7 8.7 13.9 2.9 7.6
No response 14.8 6.5 13.9 8.6 10.4
Total 100 100 100 100 100












Table III. To what extent do you think the Programme has helped to strengthen innovation in the National 
Health System?
HA = hospital administrator; RM = research manager (includes: managers of research foundations, hospital research directors 
and heads of research centres); HS= head of hospital services and units; GL= research group leader. 
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administrator and the research manager of middle-
sized hospitals with strong research capacities, 
expressly mentioned the researchers’ capacity for 
innovation and their contribution to the increase in 
the hospitals’ capacity for innovation. The hospital 
manager noted their effect on human capital, while 
the research manager mentioned their influence on 
the hospital’s technological capital. 
Although FIS hosts rarely mentioned innovation 
explicitly as one of the effects of the incorporation 
of FIS researchers, they did implicitly mention 
technological innovation. According to 19.4% of 
them, the main contribution of FIS researchers 
was their methodological training, i.e., the 
incorporation of new technologies and techniques 
to the host groups, units or hospitals (Rey-Rocha 
and Martín-Sempere, 2012). These technologies 
and techniques, once incorporated into the groups, 
formed part of their technological capital, and by 
extension became part of the technological capital 
of the hospitals and research centres. Some 
respondents (9.7%) considered this to be one of 
the main added values provided by FIS researchers:
Innovation in medicine is more complicated. In any 
case, the incorporation of FIS researchers allowed 
us to apply techniques already in existence, but 
that we had not applied before. This does not make 
it possible for you to innovate, but it does make 
you aware of innovation that takes place. (Head of 
a hospital service)
There are technologies that we would not have 
incorporated without the FIS researcher. (Research 
group leader)
According to the leader of a productive research 
group of recognized national and international 
prestige, these researchers:
…bring in new techniques that allow the work to 
take a giant leap forward, and for some groups 
I know this has marked a turning point in their 
work. 
This is the case, for instance, in a cancer research 
group, whose leader noted:
We are haematologists and physicians, and 
we admit our weakness in research. The FIS 
researcher set up all the techniques. Without 
him we could not have set up the arrays. 
This is an aspect that is especially relevant from 
the point of view of research group leaders, and is 
one of the two effects they mentioned most often 
(34.3%). 
Innovation is not produced exclusively in the 
field of new technologies, but also covers the 
areas of institutional management, organization 
and strategic orientation. Along these lines, the 
effects on the organizational capital of hospitals, 
specifically in the organization of hospital research 
(a clear example of non-technological innovation), 
is another innovation-related aspect that was 
identified by FIS hosts as one of the effects of the 
incorporation of FIS researchers. This particular 
was mentioned by 7.6% of the hosts, and 5% 
considered it one of the main added values 
provided by FIS researchers. Organizational 
innovation is essential in the health sector. One of 
the hospital administrators we surveyed summed 
up how essential organizational innovation is in the 
healthcare sector: 
The introduction of technological innovation 
has to involve organizational change. If we 
incorporate computed axial tomography 
and use it as just another technology, this 
is an additional expense; if we do not use it 
selectively for only some patients rather than 
for just any patient (organizational change) it 
is an expense. Research lines that investigate 
the technological–organizational–attitudinal 
innovation triad should be favoured.
Nevertheless, organizational innovation was 
rare, as indicated by the survey data (Table I) and 
as some FIS hosts noted:
I do not think that research carried out by FIS 
researchers has changed clinical practice at 
their host centres. They did not have the time. 
I haven’t seen them create any spin-offs either. 
(Research group leader)
Innovation means the ability to do what we do 
in a different way. In this regard, I do not think 
this has been achieved. We are at a quantitative 
stage (we have more grants and more papers), 
but haven’t reached the qualitative stage 
yet. Innovation is not only technology. It 
is organizational innovation and attitudinal 
innovation. (Hospital administrator)
Our analysis of the final reports from FIS 
researchers at the end of their contracts showed 
that an average of 0.3 patent applications were 
filed per capita, and an average of 0.1 patents 
per capita were awarded (Table IV). These are 
absolute numbers that should be considered not in 
themselves, but rather in comparison with figures 
for other researchers in the fields of Biomedicine 
and Health Sciences, both in the healthcare sector 
and in the academic and university sector. Studies 
that have appeared to date usually present data on 
a macro or meso scale, and few data are available 
on technological productivity at the micro scale of 
groups or individuals. 
The study by Rey-Rocha et al. (2006) on the 
individual productivity of members of research 
groups in the Biology and Biomedicine area of 
the Spanish Council for Scientific Research (CSIC) 
provides some data on technological productivity 
by individuals, which can be compared with the 
findings reported here. CSIC researchers were 
awarded an average of 0.4 patents per capita during 
the period from 1998 to 2002 (Table IV), a much 
higher figure than FIS researchers during their 
six-year contracts. Nevertheless, this comparison 
should be considered as merely exploratory 
because of the different characteristics of the two 
samples. Among other considerations, the data for 
the population studied here refer to technological 
productivity resulting exclusively from work done 
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during the six-year FIS contract, and do not take 
into account results based on work done during 
previous postdoctoral training. In contrast, the 
analysis of CSIC researchers’ productivity was 
based on patents granted during the five-year 
period from 1998 to 2002, and some of the results 
obtained during this period may have been the fruit 
of work done before 1998. Moreover, this difference 
in the rates of successful patent application was 
very likely influenced by the different professional 
contexts in which these researchers worked: 
academic and purely research-oriented in the case 
of CSIC employees, versus mainly hospital-based 
(therefore aimed mainly at providing healthcare) 
in the case of FIS researchers.
6. DISCUSSION AND CONCLUSIONS
This paper has explored the role of researchers 
as innovation drivers in the public healthcare 
sector. To this end, we have first reviewed the main 
theoretical approaches and conceptual frameworks 
used to study innovation, and have discussed their 
suitability and relevance to research such as ours, 
which aims to understand innovation in healthcare. 
We have then considered the role of public 
hospitals in innovation as well as in economic and 
social development, and have identified this role as 
the ‘fourth mission’ of hospitals in addition to their 
widely recognized threefold function of healthcare 
provision, education and research. We have 
argued in favour of the evolution of healthcare 
hospitals towards a type of operation termed the 
‘entrepreneurial hospital’, and have suggested that 
this process requires a ‘research revolution’ and an 
‘innovation and transfer revolution’, in accordance 
with the terms used in the Triple Helix model. More 
specifically, we have used the FIS/Miguel Servet 
Research Contract Programme as the basis for a 
case study to explore the extent to which basic 
researchers can contribute to this shift by fostering 
innovation at research and healthcare centres 
affiliated with the NHS in Spain. 
Our findings indicate that the role of researches 
as R&D-based innovation drivers was limited, as 
evidenced by participant’s assessments and the 
hosts’ views. The FIS researchers contributed to 
innovation mainly by providing research groups with 
new techniques and technologies. This represented 
a type of intra-organizational innovation based 
on the incorporation of technologies developed 
elsewere. In this regard, the incorporation of these 
researchers does not seem to have surpassed 
the model of innovation based on the extension 
of foreign innovation, which Meneu et al. (2005) 
considered predominant in Spain. 
Although most FIS researchers felt they had 
helped to apply and even develop new techniques, 
few of them identified this contribution as an 
innovation or were aware that it can be considered 
as such. Their attitude may be considered evidence 
that many researchers who participated in the 
Programme assume that innovation is defined 
according to the ‘Oslo conception’ (Echeverría, 
2008) based on the Schumpeterian tradition 
according to which innovation primarily concerns 
economic and business values. 
The incorporation of FIS researchers helped few 
Spanish NHS research groups and centres to make 
substantial progress toward becoming innovation 
generators or increasing their innovation capacity. 
As Font et al. (2008) pointed out, “although 
innovation does not always guarantee better 
results in the short term, it almost always facilitates 
the development of new models to achieve them, 
new techniques and approaches that redefine the 
limits of what is possible”. Taking into account the 
importance for contemporary research of access to 
and opportunities to use advanced technologies, 
along with the knowledge of these techniques, the 
acquisition of new techniques by some research 
groups and healthcare centres could reasonably be 
assumed to start them down the road to new lines 
of action leading to better results in the middle and 
long term.
In this regard, research-based innovation must 
be understood as a long-term output. Innovation 
in the healthcare public sector resulting from 
R&D activities must be seen as the result not of 
single discrete changes, but as the result of (as 
stated in the third edition of the Oslo Manual 
Table IV. Patent applications and patents awarded to FIS researchers during their contracts. Comparison 
with CSIC researchers in the Biology and Biomedicine area
Includes all patents (domestic, foreign and international)
* Source: Rey-Rocha et al. (2006)






Patent applications per researcher No data 0.3±0.8 (0-4) 0
Patents awarded per researcher 0.4±0.9 (0-6) 0 0.1±0.4 (0-3) 0
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[OECD/Eurostat, 2005]) “a series of incremental 
changes, provided those changes together amount 
to a substantial improvement” (Bloch, 2007). 
Thus, time is needed to undertake these changes 
and see innovations resulting from research. 
Insufficient time was identified by our informants 
as an important reason why the incorporation of 
FIS researchers did not contribute significantly to 
strengthening innovation in the Spanish NHS, as 
six years was considered too short a period for their 
contributions to materialize. Consequently, further 
research will be needed to investigate whether the 
activity of researchers at public healthcare centres 
will result in innovations and transfer processes 
throughout their subsequent research careers 
after completing work under the terms of their FIS 
contract. Ultimately, the study of FIS researchers’ 
career paths will provide an opportunity to obtain 
empirical evidence to corroborate Friedman’s 
(2002) claim that “basic research is the key to 
future innovation”. 
As we have seen, most of the work done by FIS 
researchers involved basic research, and FIS hosts 
confirmed this point as being one of the likely 
reasons why FIS researchers were not more focused 
on innovation. Moreover, most of the groups FIS 
researchers joined for the duration of their contract 
were groups that worked in mainly clinical research. 
As a result, most techniques applied or developed 
by FIS researchers fall within both basic-oriented 
and more clinical-oriented fields such as molecular 
biology and communication and image engineering. 
This is consistent with Bigorra’s (2010) new 
model of biomedical and technological innovation 
resulting from advances in the knowledge of the 
molecular basis of diseases and the convergence 
between biology and engineering thanks to 
new communication and imaging technologies. 
This kind of collaboration may be able to foster 
innovation through the promotion of interactions 
between basic researchers, clinical researchers 
and healthcare professionals, e.g., by favouring 
translational research. As we reported previously 
(Rey-Rocha and Martín-Sempere, 2012), policy 
actions intended to enhance human resources in 
R&D within the hospital environment may play a 
valuable role in promoting translational research, 
which may in turn result in innovation and transfer.
In line with the FIS Programme objectives and 
evaluation criteria, which assess researchers’ 
activity and performance on the basis of their 
leadership capabilities and scientific productivity 
(articles published in journals that have been 
assigned an impact factor), FIS researchers focus 
their efforts on scientific publications7 rather than 
patenting, commercial or entrepreneurial activities. 
Consequently, FIS researchers obtain fewer patents, 
at least compared to other researchers such as those 
employed by CSIC. A challenge for further research 
is to analyse patenting activity at hospitals as an 
indicator of R&D-based innovation, and to identify 
the factors that influence this activity.
Although an overall objective of the present 
study was to investigate researchers’ opportunities 
to become drivers of innovation in the hospital 
setting, we also wished to further identify the 
likely effects of science-based innovation on the 
Spanish NHS. The FIS/Miguel Servet Research 
Contract Programme provides opportunities for 
further research to answer a number of questions. 
i) Which factors influence the capacity to produce 
and incorporate innovation in the public health 
arena? ii) Which types of activities, resources 
and social relationships are involved in these 
processes? iii) Which contexts favour innovation? 
iv) How receptive to innovation are healthcare 
centres and their associated R&D centres? v) 
What is the role of healthcare institutions and 
institutions that manage public healthcare services 
and R&D programmes? vi) Which types of people 
are likely to become innovators? vii) How might 
the development of the foregoing factors foster the 
innovation capacity and enhance performance at 
these institutions? viii) What are the organizational 
and social effects of innovation in healthcare?
Some limitations in the data and their 
interpretation need to be recognized. Our findings 
cannot be generalized to other populations of 
researchers or to contexts other than the Spanish 
NHS. It is important to consider that Spanish 
NHS hospitals, in general, are characterized by a 
traditional prevalence of clinical research, deficits 
in the transfer of the research-based knowledge 
to clinical practice, a limited role in the innovation 
process, a shortage of qualified personnel with 
technological skills, and the absence of an 
established research career path. Moreover, the 
validity of the results of our study will ultimately 
rest on replication in other populations and 
settings, further research with different analytical 
techniques, public discussion and debate by other 
researchers and actors in other study populations, 
and the response of decision-makers and 
information users to our analysis. 
As emphasized in the introduction, among the 
factors that hinder innovation in the Spanish health 
sector are the insufficient number of institutionally 
supported R&D programmes and technical 
obstacles arising from the shortage of qualified 
personnel with technological skills (Oteo-Ochoa 
and Repullo-Labrador, 2005). In this connection, 
stronger human resource programmes to 
support the incorporation of highly qualified basic 
researchers into hospital-based research efforts 
may help support the ‘fourth mission’ of hospitals 
within the Spanish NHS system.
In the line with the Publin Report on Innovation 
in the Public Sector (Koch et al., 2006), Spanish 
NHS healthcare and research centres face the 
challenge of developing “learning strategies needed 
to find, understand and make use of competences 
developed elsewhere”. According to the concept 
first introduced by Cohen and Levinthal (1990), 
centres should develop their absorptive capacity, 
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i.e., their ability to “recognize the value of new 
information, assimilate it, and apply it” not only 
“for commercial ends” as stated by these authors, 
but for the benefit of healthcare provision. But 
these centres should also be capable of identifying 
and appreciating intra-organizational innovation 
within their own operations. For public hospitals 
and health research centres to create and maintain 
an innovation baseline, they will need to recognize 
the innovation cycle, opportunities for innovation, 
innovative ideas and ultimately the innovations 
generated within the organization itself. 
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NOTES
[1] The Carlos III Health Institute is the public organism 
responsible for funding and managing most biomedical 
research in Spain.
[2] Resolution of 22 February 2010. Boletín Oficial del 
Estado number 58, 8 March 2010, pages 23295-377.
[3] The concept of hidden innovation was originally 
developed by Hansen and Serin (1997). It has been defined by 
NESTA (2007) as “innovation activities that are not reflected 
in traditional indicators such as investments in formal R&D of 
patents awards”.
[4] ‘Social innovation’ is a notion that considers “the 
innovative activities and services that are motivated by the 
goal of meeting social need and that are predominantly 
developed and diffused through organizations whose primary 
purposes are social” (Mulgan, 2007).
[5] In Spain this has been accomplished through an internal 
resident physicians training programme known as the MIR 
Programme, which started in 1998 (FECYT, 2005b).
[6] Examples of such arrangements at the Spanish NHS 
are the creation of Research Foundations at public hospitals 
(FECYT, 2005b) or the more recent actions and programmes 
of the Health Research Fund (FIS) and the Carlos III Health 
Institute, e.g. the Thematic Networks for Cooperative Research 
(RETICS), the Biomedical Research Networking Centres 
(CIBER), the Programme for the Promotion of Research or the 
Human Resources on R&D programmes, including the FIS/
Miguel Servet Programme, among others (Font et al., 2008; 
Gomis, 2009).
[7] Compared to patent data, it is of note that almost 
all researchers who completed their contract published at 
least one article in a Web of Science-indexed (ISI) journal. 
On average, they published more than fourteen articles 
per capita during the six-year duration of their programme 
contract (Rey-Rocha et al. 2012).
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